ASXClosure of A$5M Loan Facility with Major Shareholders
other announcement
LUMOS DIAGNOSTICS ORDINARY (LDX) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Change of Director's Interest Notice - SL
director_dealing announcement
Google NewsLumos Diagnostics (ASX:LDX): Diagnostics Stock Rebounds as Healthcare Small Caps Find Momentum - Kalkine
Lumos Diagnostics (ASX:LDX): Diagnostics Stock Rebounds as Healthcare Small Caps Find Momentum Kalkine
KalkineCould Lumos Diagnostics Be Approaching a Turning Point?
Highlights Analysts expect Lumos Diagnostics to move towards profitability in the near term. The company continues expanding its point-of-care diagnostic capabilities across healthcare markets. A debt-free balance sheet provides additional financial flexibility as growth initiatives progress. Lumos Diagnostics is gaining attention as analysts assess its path towards profitability, supported by healthcare sector demand and a debt-free balance sheet. Healthcare technology companies often attrac...
Analysts Are Optimistic We'll See A Profit From Lumos Diagnostics Holdings Limited (ASX:LDX) - simplywall.st
Analysts Are Optimistic We'll See A Profit From Lumos Diagnostics Holdings Limited (ASX:LDX) simplywall.st
Change of Director's Interest Notice - CR
director_dealing announcement
Investor Presentation - FebriDx US Commercial Update
other announcement
Change of Director's Interest Notice - DW
director_dealing announcement
StockheadLumos gains traction in US FebriDx rollout with strong early reimbursement signals
Lumos provides positive update on early commercial rollout of FebriDx test across US urgent care networks. ... Read More The post Lumos gains traction in US FebriDx rollout with strong early reimbursement signals appeared first on Stockhead.
FebriDx U.S. Rollout and Reimbursement Update - Amended
other announcement
FebriDx Paediatric Study Enrolment Milestone Achieved
other announcement
Lumos receives US$0.5m CLIA waiver milestone payment
other announcement
Change of Director's Interest Notice - CR
director_dealing announcement
Change of Director's Interest Notice - SL
director_dealing announcement
Change of Director's Interest Notice - SL
director_dealing announcement
Insiders In Lumos Diagnostics Holdings Left Out From 11% Price Rise After Disposing Stock - simplywall.st
Insiders In Lumos Diagnostics Holdings Left Out From 11% Price Rise After Disposing Stock simplywall.st
Is Lumos Diagnostics (ASX:LDX) Shaping ASX All Ordinaries Healthcare Landscape?
Highlights Lumos Diagnostics schedules reporting update alongside investor webinar. Share purchase plan progresses toward final stage within capital framework. Healthcare diagnostics sector reflects continued operational engagement. Lumos Diagnostics outlines reporting plans and investor engagement while advancing its share purchase plan, reflecting continued activity within the healthcare diagnostics sector. The healthcare diagnostics sector represents a critical segment within the Aus...
Lumos receives US$5m FebriDx milestone payment from PHASE
other announcement
Lumos lands lucrative deal to manufacture mould detection device
Lumos lands three-year contract to manufacture Micro-Pak’s Mold Analyzer system ... Read More The post Lumos lands lucrative deal to manufacture mould detection device appeared first on Stockhead.
Lumos secures new contract manufacturing agreement
other announcement
Lumos to access $1b US market with diagnostic device, raises $20m
Lumos completes US$14 million ($20m) placement to institutional investors to support US rollout of FebriDX ... Read More The post Lumos to access $1b US market with diagnostic device, raises $20m appeared first on Stockhead.
Lumos completes $20m placement and launches SPP
capital_raise announcement
Lumos Delivers Several Pivotal Milestones in 1H FY26
other announcement
Lumos Completes Enrolment Milestone for Paediatric Study
other announcement